Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2022-05-10 | 2022-03 | -0.12 | N/A | N/A | N/A |
2022-03-28 | 2021-12 | -0.13 | N/A | N/A | N/A |
2021-11-10 | 2021-09 | -0.47 | N/A | N/A | N/A |
2021-08-12 | 2021-06 | -0.8 | N/A | N/A | N/A |
2021-05-13 | 2021-03 | -0.83 | N/A | N/A | N/A |
2021-03-18 | 2020-12 | -0.76 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2021-10-14 | HC Wainwright & Co. | Upgrade | Buy | |
2021-06-03 | Raymond James | Downgrade | Outperform | Market Perform |
2021-06-03 | Baird | Downgrade | Outperform | Neutral |
2021-05-17 | Wells Fargo | Upgrade | Underweight | |
2021-05-14 | Raymond James | Upgrade | Outperform | |
2021-02-08 | Wells Fargo | Downgrade | Overweight | Underweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-06-13 | ATHYRIUM OPPORTUNITIES FUND A, L.P. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
2021-06-13 | BIGALKE JOHN T | Director | 47.52K | Stock Award(Grant) |
2022-04-14 | D'ESPARBES ERIC | Chief Financial Officer | 423.17K | Stock Award(Grant) |
2021-11-02 | HOWE JILL ANN | Director | 76.75K | Stock Award(Grant) |
2021-06-13 | KOTZIN BRIAN L | Director | 47.52K | Stock Award(Grant) |
2021-11-07 | MOHANTY ADITYA P | Chief Executive Officer | 1.41M | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-12-30 | Athyrium Capital Management, LP | 29.86M | 62.40M | 16.21% |
2022-03-30 | Neuberger Berman Group, LLC | 6.54M | 7.59M | 3.55% |
2022-03-30 | Vanguard Group, Inc. (The) | 5.16M | 5.98M | 2.80% |
2022-03-30 | Blackrock Inc. | 1.66M | 1.93M | 0.90% |
2022-03-30 | Geode Capital Management, LLC | 1.15M | 1.34M | 0.63% |
2022-03-30 | Susquehanna International Group, LLP | 955.32K | 1.11M | 0.52% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-12-30 | Vanguard Total Stock Market Index Fund | 3.03M | 6.32M | 1.64% |
2021-12-30 | Vanguard Extended Market Index Fund | 1.58M | 3.29M | 0.86% |
2022-02-27 | Fidelity Extended Market Index Fund | 615.33K | 830.69K | 0.33% |
2022-02-27 | Fidelity Total Market Index Fund | 210.77K | 284.53K | 0.11% |
2022-02-27 | Fidelity Series Total Market Index Fund | 121.33K | 163.79K | 0.07% |
2022-02-27 | Fidelity NASDAQ Composite Index Fund | 80.80K | 109.08K | 0.04% |
-
Wahaha so cheap. Christmas sales
-
Freedom of speech entails the right to share your Assets. If you don’t like to see them, then don’t click on it.
-
Know why it can’t go below $2.41 ?
That’s because we are loading. Thanks for the discounts.
-
Show me that you can move above $2.50 and hold.
-
Let’s go. Waiting for this Green Dick all morning long. Better late than never
-
Ah, back to sleep. This will rise as the Santa Clause Rally starts unfolding soon.
-
I just bought. Probably why PROG is turning REd in a Green Day.
-
Shorts can be in the RED for months without blinking. But Retails will cry their lungs out when down by 5%.
-
Shorts have patience. Do you retails have patience and Diamond Balls ?
-
-
Let’s hope that this stock will make us rich
-
That’s so bullish. Reduced cash burn and generate enough cash in hands until 2023. So offerings will be off the table. Perfect to load up here.
-
Meme stocks are down. PROG will likely follow them to the same pit hole.
-
VIX is up 24 points. Good grief. Futures are down. Stock will likely trend downward with low volume. Bears will show up.
-
You are basically too stupid to gamble with options. Start buying shares. Then you don’t have to mope about losing your money over gambling.
-
I am bullish for PROG. But seriously, Pfizer meeting today and its COVID pill has nothing to do with PROG.
-
-
Pfizer event tomorrow is all about COVID. It has nothing to do with PROG. People needs to stop fabricating up lies and fake news. Be Bullish for the right reasons.
-
-
With hedge fund manipulations, PROG will likely come back down to $2.42 support 200 Day Moving average line.
-
Progenity Announces Successful Transfer of Liquid Biopsy Technologies
globenewswire.com • -
Progenity to Become Biora Therapeutics as it Completes Transformation
globenewswire.com • -
Progenity Announces Two Poster Presentations at Controlled Release Society 2022
globenewswire.com • -
Should You Invest in These Penny Stocks Next Month? 3 to Watch
pennystocks.com • -
Penny Stocks To Buy Now? 4 Short Squeeze Stocks To Watch This Week
pennystocks.com • -
Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022
globenewswire.com • -
Top Penny Stocks to Buy Right Now? 3 to Watch in Mid-February
pennystocks.com • -
Top Reddit Penny Stocks That Investors Are Watching Right Now
pennystocks.com • -
3 Penny Stocks Climbing During Today's Trading Session
pennystocks.com • -
These 4 Penny Stocks Exploded Today, Here's Why
pennystocks.com • -
Here's 3 Trending Penny Stocks to Add to Your Watchlist in February
pennystocks.com • -
5 Top Penny Stocks To Buy Now According To Reddit
pennystocks.com •